BioLargo, Inc.
BLGO
$0.2365
$0.00351.50%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -88.83% | -21.77% | -7.56% | 43.76% | 39.25% |
| Total Depreciation and Amortization | -1.47% | 13.33% | 0.00% | -31.82% | 15.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 208.50% | -198.52% | -21.62% | -72.03% | 89.37% |
| Change in Net Operating Assets | -24.71% | -3,622.22% | -95.28% | 299.30% | -42.79% |
| Cash from Operations | -18.27% | -972.85% | -131.39% | 24,150.00% | 99.76% |
| Capital Expenditure | 164.10% | 89.11% | 58.52% | -491.10% | 28.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -46.15% | 89.11% | 58.52% | -491.10% | 28.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 50.00% | -33.33% | 40.00% | -109.09% | 558.33% |
| Issuance of Common Stock | -- | -23.35% | -7.90% | 79.54% | 162.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -87.85% |
| Cash from Financing | 108.38% | -23.52% | -7.76% | 42.31% | 50.10% |
| Foreign Exchange rate Adjustments | 291.67% | 119.67% | -163.54% | 182.76% | -11,700.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.17% | -305.83% | -46.17% | 60.36% | 193.25% |